Navigation Links
Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance
Date:9/9/2010

Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years... -- ABBOTT PARK, Ill., Sept. 9 /PRNewswire-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Corporate Social Responsibility Click to view news release full screen  

Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance

   

Abbott Leads the Industry in Environmental Management and Climate Policy, Responsible Marketing Practices, Standards for Suppliers, Innovative Philanthropy

ABBOTT PARK, Ill., Sept. 9 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today that it was included on both the Dow Jones Sustainability World Index and North America Index for the sixth consecutive year.  The Dow Jones Sustainability Indexes (DJSI) recognize the leading companies in each industry sector for responsible economic, environmental and social performance.

Abbott was named the industry leader in several categories, including a score of 100 percent in environmental management and climate strategy, key areas of focus in the company's comprehensive effort to safeguard the environment.  Abbott also led the industry in responsible marketing practices, standards for suppliers, innovative philanthropy, and employee health and safety.

Abbott is one of only two U.S.-based companies in its industry sector to be listed on both the North America and World Indexes.  The company's overall score of 84 percent is significantly higher than the average score of 53 percent for other companies in the sector.

Abbott's scores increased in 19 of 23 categories compared to the previous year, demonstrating its ongoing commitment to continuous improvement in citizenship and sustainability.  This included significant improvement in the company's efforts to improve patient health outcomes, and strengthen risk and crisis management.  

"The environments in which we operate – natural, social, economic and political – are particularly sensitive and challenging, requiring companies like Abbott to be more thoughtful than ever about the ways we operate our business," said Miles D. White, chairman and chief executive officer, Abbott.  "We believe that Abbott has met that challenge, across the spectrum of its business activities."

As a member of the prestigious Dow Jones Sustainability World Index, Abbott is among the top 300 of the 2,500 largest companies worldwide in terms of sustainability. The DJSI annual review considers sustainability leaders from each industry on a global and regional level, and involves thorough analyses of corporate governance, risk management, branding, climate change mitigation, supply chain standards, labor practices and related citizenship issues.

About Abbott's Approach to CitizenshipGlobal citizenship is an integral part of Abbott's mission to improve people's lives, focused on four key areas:  innovating for the future, enhancing access to health care, protecting patients and consumers, and safeguarding the environment.  Working in partnership with others, Abbott leverages its core business expertise and resources to create sustainable solutions in countries around the world.

In addition to being included in the Dow Jones Sustainability Indexes, Abbott ranked sixth overall on the global "100 Best Corporate Citizens List 2010" compiled by Corporate Responsibility magazine.  The company was named one of the top three "2010 Best in Class" companies in its industry sector by Storebrand Investments, a leading socially responsible investment (SRI) firm.

FORTUNE magazine also named Abbott the No. 1 Most Admired Company in its industry sector in 2010, in part for the company's strong performance in social responsibility.  In addition to these global honors, Abbott has been recognized for its sustainability efforts in countries around the world, including Brazil, China, Denmark, Finland, Ireland, Italy, Korea, Mexico, Singapore, Tanzania and the United States.  

To learn more about Abbott's sustainability initiatives and to read or download the company's 2009 global citizenship report, please visit www.abbott.com/citizenship.

About Abbott Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.


'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Abbott Completes Acquisition of Piramals Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
2. Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment
3. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
4. Abbotts SIMCOR ® ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths
5. Abbott to Feature Novel Tests and New Upgrades to Testing Platforms at American Association for Clinical Chemistry Lab Expo
6. Abbott Receives FDA Clearance for Molecular Diagnostic Test for Detection of Chlamydia and Gonorrhea Infections
7. Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting
8. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
9. Abbotts Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
10. Abbotts Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
11. New Data Reinforces Safety Profile of Abbotts Market-Leading XIENCE V(R) Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... CAMBRIDGE, Mass. , Feb. 27, 2017  Infinity ... presenting at the Cowen and Company 37 th ... 4:00 p.m. ET in Boston, MA. ... accessible on the Investors/Media section of Infinity,s website at ... days following the event. About Infinity,Infinity is ...
(Date:2/27/2017)... February 27, 2017 Now in its ... companies that are most successful at developing and commercialising innovation. ... The ... the same molecule to two different companies in early phase, ... on systematic, objective analysis of each company,s performance between 2011 and 2016, ...
(Date:2/27/2017)... Feb. 27, 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ ... Craig , M.D., Ph.D., as President and Chief Executive Officer ... 20, 2017. Dr. Craig succeeds Richard Love , interim ... company,s Board of Directors.  Dr. Craig has over 20 years ... the US and Europe . ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast Health Centre ... Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of ... showcases the Centre's commitment to innovation in drug rehab and alcohol treatment strategies ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of ... concern over nerve agents and the deadly use of chemical weapons. Many questions exist ... how even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan ...
(Date:2/26/2017)... ... February 26, 2017 , ... LatitudeC Baby Products, an innovative ... it would be offering some it’s exclusive product line to the public through ... unique baby clothing/feeding products, will team up with AMAZON to distribute a limited ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging ... according to a study released today at the 1st Pan American Parkinson’s and ... proven to be effective in improving cognitive function in PD patients. This study, ...
(Date:2/24/2017)... ... February 24, 2017 , ... Houston ... at his office, Antoine Dental Center. Currently, patients can get single dental implants ... apply, but patients can learn more about these offers by contacting Antoine Dental ...
Breaking Medicine News(10 mins):